Randox recalls G-6-PDH Normal Control kits with incorrect target values for glucose-6-phosphate dehydrogenase testing. Affected lots may cause inaccurate blood test results.
The target values and ranges in these lots are incorrect.
Rando: G-6-PDH Normal Control kits with incorrect target values are being recalled. Using these kits could lead to inaccurate blood test results, which might affect diagnosis and treatment decisions.
The target values in these kits are incorrect, which means blood test results could be inaccurate. This might lead to wrong diagnoses or treatment decisions if the kits are used for glucose-6-phosphate dehydrogenase testing.
People who use these kits for blood glucose testing may have inaccurate results. Laboratory staff and healthcare providers using the kits for quality control are most at risk.
Check the lot numbers on the kit: 676PD, 701PD, or 716PD. These kits are used for in vitro diagnostic testing of blood glucose.
Look for lot numbers 676PD, 701PD, or 716PD on the G-6-PDH Normal Control kit.
G-6-PDH Normal Control (G-6-PDH CONTROL N) with Catalogue Number PD2618.
Lot numbers 676PD, 701PD, and 716PD.
The target values and ranges in these lots are incorrect, which could lead to inaccurate blood test results.
We’ve drafted a message you can send Randox to request your refund or repair — edit it as you like.
Subject: Recall Z-1255-2019 — Randox Randox Hello, I own a Randox that is covered by recall Z-1255-2019 from Randox. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
